Menu
Search Clinical Trials
Back to Search Results
Recruiting
Astellas Study ID
1128-CL-0201

Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

Astellas Study ID
1128-CL-0201
Clinicaltrials.gov ID
NCT03941483
EUCTIS ID
N/A
EudraCT ID
N/A
jRCT ID
N/A
CN CDE ID
N/A
Get more information

Study summary

The purpose of this study is to evaluate the efficacy of postsurgery treatment with ASP1128 in subjects at risk for acute kidney injury (AKI) following CABG and/or valve surgery.

This study will also investigate the safety and tolerability of postsurgery treatment with ASP1128, and pharmacokinetic characteristics of ASP1128 in subjects at risk for AKI following CABG and/or valve surgery.

Additional Study Details

Phase
Phase 2
Product
ASP1128
Product
  • ASP1128
  • Placebo
    • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    220
    Show Additional Study Details

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery? Contact us by filling out your information to the right and we’ll respond to you.

    • A caregiver
    • A healthcare provider
    • A parent
    • A patient
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Withdrawn
      Keck School of Medicine USC
      Los Angeles, CA, United States, 90033
      Contact Us
      Recruiting
      ProMedica Toledo Hospital
      Toledo, OH, United States, 43606
      Contact Us
      Active, not recruiting
      Sarver Heart Center
      Tucson, AZ, United States, 85724
      Contact Us
      Recruiting
      Baylor Scott & White Heart Hospital
      Plano, TX, United States, 75093
      Contact Us
      Terminated
      Florida Hospital Pepin Heart Institute
      Tampa, FL, United States, 33613
      Contact Us
      Recruiting
      Indiana University Health Ball Memorial Hospital
      Muncie, IN, United States, 47303
      Contact Us
      Recruiting
      Delmarva Heart, LLC
      Salisbury, MD, United States, 21804
      Contact Us
      Recruiting
      WVU Heart and Vascular Institute
      Morgantown, WV, United States, 26506
      Contact Us
      Recruiting
      St. Vincent Heart Center
      Indianapolis, IN, United States, 46290
      Contact Us
      Recruiting
      Minneapolis Heart Institute
      Minneapolis, MN, United States, 55407
      Contact Us
      Terminated
      Ascension Genesys Hospital
      Grand Blanc, MI, United States, 48439
      Contact Us
      Active, not recruiting
      JEHM clinical Research Group
      Palm Springs, CA, United States, 92262
      Contact Us
      Recruiting
      Fairview Hospital - Cleveland Clinic
      Cleveland, OH, United States, 44111
      Contact Us
      Recruiting
      Maine Medical Center
      Portland, ME, United States, 04102
      Contact Us
      Recruiting
      Inova Heart and Vascular Institute
      Falls Church, VA, United States, 22042
      Contact Us
      Recruiting
      University of Texas Health Science Center
      San Antonio, TX, United States, 78229
      Contact Us
      Recruiting
      VA Medical Center
      Washington, DC, United States, 20422
      Contact Us
      Terminated
      Health Park Medical Center
      Fort Myers, FL, United States, 33908
      Contact Us
      Withdrawn
      University of Florida- Jacksonville
      Jacksonville, FL, United States, 32209
      Contact Us
      Recruiting
      Baptist Medical Center
      Jackson, MS, United States, 39202
      Contact Us
      Withdrawn
      Medical City Dallas Hospital
      Dallas, TX, United States, 75230
      Contact Us
      Recruiting
      Southern Illinois University
      Springfield, IL, United States, 62794
      Contact Us
      Recruiting
      Vanderbilt University
      Nashville, TN, United States, 37232
      Contact Us
      Recruiting
      Shands Hospital
      Gainesville, FL, United States, 32610
      Contact Us
      Recruiting
      IU Health - Methodist
      Indianapolis, IN, United States, 46202
      Contact Us
      Recruiting
      Duke University Medical Center
      Durham, NC, United States, 27710
      Contact Us
      Recruiting
      Luthern Medical Group
      Fort Wayne, IN, United States, 46804
      Contact Us
      Recruiting
      Barnes Jewish Hospital
      St. Louis, Mo, United States, 63110
      Contact Us
      Recruiting
      Lourdes Cardiology Services
      Voorhees, NJ, United States, 08035
      Contact Us
      Recruiting
      Hartford Hospital
      Hartford, CT, United States, 06102
      Contact Us
      Recruiting
      Jacksonville Center for Clinical Research
      Jacksonville, FL, United States, 32207
      Contact Us
      Recruiting
      Heart Center Research, LLC
      Huntsville, AL, United States, 35801
      Contact Us
      Recruiting
      Morton Plant Hospital
      Clearwater, FL, United States, 33756
      Contact Us
      Recruiting
      Moses H. Cone Memorial Hospital
      Greensboro, NC, United States, 27401
      Contact Us
      Recruiting
      Mid Michigan Medical Center
      Midland, MI, United States, 48670
      Contact Us
      Recruiting
      University Hospitals - Cleveland Medical Center
      Cleveland, OH, United States, 44106
      Contact Us
      Recruiting
      MercyOne Iowa Heart Center
      Des Moines, IA, United States, 50314
      Contact Us
      Recruiting
      University of Utah Hospitals and Clinics
      Salt Lake City, UT, United States, 84132
      Contact Us
      Recruiting
      University of Oklahoma
      Oklahoma City, OK, United States, 73104
      Contact Us
      Recruiting
      University of Virginia Health System
      Charlottesville, VA, United States, 22908
      Contact Us
      Recruiting
      St. Luke's Hospital of Kansas City
      Kansas City, Mo, United States, 64111
      Contact Us
      Recruiting
      Columbia University Irving Medical Center
      New York, NY, United States, 10032
      Contact Us
      Recruiting
      Medical University of South Carolina
      Charleston, SC, United States, 29425
      Contact Us
      Trial info
      Follow Trial
      Age
      35+ years
      Diamond icon
      Condition
    • Kidney Disease
      • Gender icon
      Sex
      Female & Male
      Calendar icon
      Trial Dates
      Nov 2019 - Jan 2022
      Additional Study Details
      Inclusion Criteria
      • Subject agrees not to participate in another interventional study after signing the informed consent form and until the end of study (EoS) visit has been completed.
      • Subject is ≥ 35 years of age at the time of screening (visit 1).
      • Subject undergoing non-emergent open chest cardiovascular surgery with the use of cardiopulmonary bypass pump (CPB) (i.e., coronary artery bypass graft (CABG) and/or valve surgery [including aortic root and ascending aorta surgery without circulatory arrest]) within 4 weeks of screening (visit 1).
      • Subject is at risk of developing acute kidney injury (AKI) following cardiovascular surgery, i.e., has 1 or more of the following AKI risk factors:
        • Age at screening of ≥ 70 years
        • Documented history of eGFR < 60 mL/min per 1.73 m^2 as per Modification of Diet in Renal Disease Study (MDRD) or Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (or documented measured glomerular filtration rate assessment) (history needs to be present for at least 90 days prior to screening, and eGFR at screening or baseline needs to be < 60 mL/min per 1.73 m^2, as well as per CKD-EPI equation.)
        • Documented history of congestive heart failure requiring hospitalization. This condition should exist for ≥ 90 days prior to screening.
        • Documented history of diabetes mellitus (type 1 or 2) of ≥ 90 days prior to screening, and subject is on active antidiabetic medication treatment for ≥ 90 days.
        • Documented history of proteinuria/albuminuria at any time point before screening (urinary dipstick result of ≥ 2+, documented urinary albumin creatinine ratio measurement of ≥ 300 mg/g, or documented total quantity of protein in a 24-hour urine collection test ≥ 0.3 g/day)
      • Subject must have the ability and willingness to return for all scheduled visits and perform all assessments.
      • Female subject is eligible to participate if she is not pregnant and at least 1 of the following conditions applies:
        • Not a woman of childbearing potential (WOCBP), OR
        • WOCBP who agrees to follow the contraceptive guidance throughout the treatment period and for at least 30 days after the final study drug administration.
      • Female subject must agree not to breastfeed starting at screening and throughout the study period, and for 30 days after the final study drug administration.
      • Female subject must not donate ova starting at screening and throughout the study period, and for 30 days after the final study drug administration.
      • Male subject with female partner(s) of child-bearing potential must agree to use contraception during the treatment period and for at least 30 days after the final study drug administration.
      • Male subject must not donate sperm during the treatment period and for at least 30 days after the final study drug administration.
      • Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent or use a condom for the duration of the pregnancy or time partner is breastfeeding throughout the study period and for 30 days after the final study drug administration.
      MaximizeExclusion Criteria

        At Screening:

      • Subject has received investigational drug within 30 days or 5 half-lives, whichever is longer, prior to screening.
      • Subject has received RRT within 30 days prior to screening.
      • Subject has CKD stage 4 or 5, or stage 3 (i.e., eGFR 30-59 mL/min per 1.73m^2) with a known history of eGFR < 30 mL/min per 1.73 m^2 as per CKD-EPI or MDRD equation within 6 months prior to screening.
      • Subject has a prior kidney transplantation.
      • Subject has a known or suspected glomerulonephritis (other than Diabetic Kidney Disease).
      • Subject has confirmed or treated endocarditis or other current active infection requiring antibiotic treatment within 30 days prior to screening.
      • Subject is using prohibited.
      • Subject has a prior history of intravenous drug abuse within 1 year prior to screening.
      • Subject has a known chronic liver disorder with Child-Pugh B or C classification.
      • Subject has any of the following abnormal liver or kidney function parameters:
        • Alanine aminotransferase (ALT), aspartate aminotransferase (AST) > 2 times the upper limit of normal (ULN) or bilirubin increased to > 1.5 times the ULN.
        • eGFR < 30 mL/min per 1.73 m^2 as per CKD-EPI equation.
      • Subject has use of left ventricular assist device, intra-aortic balloon pump or other cardiac devices, or catecholamines within 7 days prior to screening.
      • Subject has surgery scheduled to be performed without CPB (i.e., “Off-Pump” surgery).
      • Subject has surgery scheduled to be performed under conditions of circulatory arrest, including planned deep hypothermic circulatory arrest.
      • Subject has surgery scheduled for aortic dissection.
      • Subject has surgery for a condition that is immediately life-threatening.
      • Subject has surgery scheduled to correct major congenital heart defect.
      • Subject has current or previous malignant disease. Subjects with a history of cancer are considered eligible if the subject has undergone therapy and the subject has been considered disease free or progression free for at least 5 years. Subject with completely excised basal cell carcinoma or squamous cell carcinoma of the skin and completely excised cervical cancer in situ are also considered eligible.

        • Preoperatively on the Day of Surgery:

      • Exclusion criteria 1 to 17 are applicable at this time.
      • Subject has AKI (any stage) present at presurgery baseline.
      • Subject has known or suspected infection/sepsis at time of presurgery baseline.

        • Perioperative Exclusion Criteria:

      • Subject requires Extracorporeal Membrane Oxygenation during or after completion of surgery.
      • Subject requires ventricular assist device during or after completion of surgery.
      • Subject has surgery performed “Off-Pump” at any time during surgery.

        • General:

      • Subject has other condition, which makes the subject unsuitable for study participation.
      • Female subject who is pregnant or lactating or has a positive pregnancy test within 72 hours prior to screening and/or randomization, has been pregnant within 6 months before screening assessment or breastfeeding within 3 months before screening or who is planning to become pregnant within the total study period.
      • Subject has a known or suspected hypersensitivity to ASP1128 or any components of the formulation used.

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      Find a Trial
      2

      Why are Clinical Trials Important?

      Learn More
      3

      Why Participate in a Clinical Trial?

      Discover More